Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve Un-audited Financial Results ....

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionExceptional itemResults View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.8%Reaction day

₹821.95

prior close

₹820.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.9%-0.9% vs market

Pharmaceuticals peers, median of 155sector-1.5%-1.3% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Smallcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.2

10m

+1.1

15m

+1.2

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.8-1.9-0.9-1.5-1.3

Next day

-0.2-1.7+1.5-2.1+1.9

+3.5+0.1+3.4-1.0+4.5

+0.6+0.1+0.5-1.4+2.0

+1.7+0.9+0.8-1.1+2.8

+2.1-0.7+2.8-1.4+3.4

-1.8+3.0-4.8+1.5-3.4

15d

+11.9+2.3+9.6+0.0+11.9

+17.8+2.6+15.1+0.3+17.5

+19.4-8.9+28.2-9.9+29.3

+26.9+6.2+20.7+2.5+24.4

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences has informed the stock exchanges that its Board of Directors will meet on Thursday, 5 February 2026. The main agenda is to consider and approve the Un-audited Financial Results (both Standalone and Consolidated) for the Third Quarter and Nine Months ended 31 December 2025. The trading window for company securities has already been closed from 1 January 2026 and will remain shut until 48 hours after the results are declared. The notice was signed by Runa Karan, Company Secretary & Compliance Officer, and was filed with both BSE (Scrip Code 544306) and NSE (Symbol: SAILIFE) on 22 January 2026.

Likely market impact

This is a routine regulatory filing and has no direct impact on the stock price. Investors should watch the actual Q3 results due on 5 February 2026 for any material performance updates, as the results will set the tone for the stock in the near term.

By the numbersConsolidated · Q3 FY26 vs Q3 FY25

	Q3 FY26	Q3 FY25	Change
Revenue	₹556.5 Cr	₹439.8 Cr	+26.5%
Operating profit	₹134.1 Cr	₹62.53 Cr	+114.4%
Profit after tax	₹100.4 Cr	₹53.85 Cr	+86.4%
EBITDA margin	32.3%	27.2%	+5.0 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.